Anita Sidhu - Publications

Affiliations: 
Georgetown University Medical Center, Washington, DC, United States 
Area:
Neuroscience Biology

38 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Mercado G, Castillo V, Soto P, Sidhu A. ER stress and Parkinson's disease: Pathological inputs that converge into the secretory pathway. Brain Research. PMID 27103567 DOI: 10.1016/j.brainres.2016.04.042  0.4
2015 Credle JJ, Forcelli PA, Delannoy M, Oaks AW, Permaul E, Berry DL, Duka V, Wills J, Sidhu A. α-Synuclein-mediated inhibition of ATF6 processing into COPII vesicles disrupts UPR signaling in Parkinson's disease. Neurobiology of Disease. 76: 112-25. PMID 25725420 DOI: 10.1016/j.nbd.2015.02.005  0.4
2013 Oaks AW, Sidhu A. Parallel mechanisms for direct and indirect membrane protein trafficking by synucleins. Communicative & Integrative Biology. 6: e26794. PMID 24563712 DOI: 10.4161/cib.26794  0.4
2013 Duka V, Lee JH, Credle J, Wills J, Oaks A, Smolinsky C, Shah K, Mash DC, Masliah E, Sidhu A. Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer's diseases. Plos One. 8: e75025. PMID 24073234 DOI: 10.1371/Journal.Pone.0075025  0.4
2013 Oaks AW, Marsh-Armstrong N, Jones JM, Credle JJ, Sidhu A. Synucleins antagonize endoplasmic reticulum function to modulate dopamine transporter trafficking. Plos One. 8: e70872. PMID 23967127 DOI: 10.1371/journal.pone.0070872  0.4
2013 Oaks AW, Frankfurt M, Finkelstein DI, Sidhu A. Age-dependent effects of A53T alpha-synuclein on behavior and dopaminergic function. Plos One. 8: e60378. PMID 23560093 DOI: 10.1371/journal.pone.0060378  0.4
2012 Wills J, Credle J, Oaks AW, Duka V, Lee JH, Jones J, Sidhu A. Paraquat, but not maneb, induces synucleinopathy and tauopathy in striata of mice through inhibition of proteasomal and autophagic pathways. Plos One. 7: e30745. PMID 22292029 DOI: 10.1371/journal.pone.0030745  0.4
2011 Kaul T, Credle J, Haggerty T, Oaks AW, Masliah E, Sidhu A. Region-specific tauopathy and synucleinopathy in brain of the alpha-synuclein overexpressing mouse model of Parkinson's disease. Bmc Neuroscience. 12: 79. PMID 21812967 DOI: 10.1186/1471-2202-12-79  0.4
2011 Haggerty T, Credle J, Rodriguez O, Wills J, Oaks AW, Masliah E, Sidhu A. Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson's disease. The European Journal of Neuroscience. 33: 1598-610. PMID 21453448 DOI: 10.1111/J.1460-9568.2011.07660.X  0.4
2011 Wills J, Credle J, Haggerty T, Lee JH, Oaks AW, Sidhu A. Tauopathic changes in the striatum of A53T α-synuclein mutant mouse model of Parkinson's disease. Plos One. 6: e17953. PMID 21445308 DOI: 10.1371/journal.pone.0017953  0.4
2011 Oaks AW, Sidhu A. Synuclein modulation of monoamine transporters. Febs Letters. 585: 1001-6. PMID 21396366 DOI: 10.1016/j.febslet.2011.03.009  0.4
2010 Wills J, Jones J, Haggerty T, Duka V, Joyce JN, Sidhu A. Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia. Experimental Neurology. 225: 210-8. PMID 20599975 DOI: 10.1016/j.expneurol.2010.06.017  0.4
2009 Jeannotte AM, McCarthy JG, Sidhu A. Desipramine induced changes in the norepinephrine transporter, alpha- and gamma-synuclein in the hippocampus, amygdala and striatum. Neuroscience Letters. 467: 86-9. PMID 19818834 DOI: 10.1016/j.neulet.2009.10.010  0.4
2009 Duka T, Duka V, Joyce JN, Sidhu A. Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 2820-30. PMID 19369384 DOI: 10.1096/fj.08-120410  0.4
2009 Chen J, Rusnak M, Lombroso PJ, Sidhu A. Dopamine promotes striatal neuronal apoptotic death via ERK signaling cascades. The European Journal of Neuroscience. 29: 287-306. PMID 19200235 DOI: 10.1111/j.1460-9568.2008.06590.x  0.4
2009 Jeannotte AM, McCarthy JG, Redei EE, Sidhu A. Desipramine modulation of alpha-, gamma-synuclein, and the norepinephrine transporter in an animal model of depression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 987-98. PMID 18800064 DOI: 10.1038/npp.2008.146  0.4
2008 Jeannotte AM, Sidhu A. Regulated interactions of the norepineprhine transporter by the actin and microtubule cytoskeletons. Journal of Neurochemistry. 105: 1668-82. PMID 18331289 DOI: 10.1111/j.1471-4159.2008.05258.x  0.84
2008 Moussa CE, Rusnak M, Hailu A, Sidhu A, Fricke ST. Alterations of striatal glutamate transmission in rotenone-treated mice: MRI/MRS in vivo studies. Experimental Neurology. 209: 224-33. PMID 18028910 DOI: 10.1016/j.expneurol.2007.09.023  0.4
2007 Jeannotte AM, Sidhu A. Regulation of the norepinephrine transporter by alpha-synuclein-mediated interactions with microtubules. The European Journal of Neuroscience. 26: 1509-20. PMID 17714497 DOI: 10.1111/j.1460-9568.2007.05757.x  0.84
2006 Duka T, Rusnak M, Drolet RE, Duka V, Wersinger C, Goudreau JL, Sidhu A. Alpha-synuclein induces hyperphosphorylation of Tau in the MPTP model of parkinsonism. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 2302-12. PMID 17077307 DOI: 10.1096/fj.06-6092com  0.4
2006 Kozikowski AP, Gaisina IN, Petukhov PA, Sridhar J, King LT, Blond SY, Duka T, Rusnak M, Sidhu A. Highly potent and specific GSK-3β inhibitors that block tau phosphorylation and decrease α-synuclein protein expression in a cellular model of Parkinson's disease Chemmedchem. 1: 256-266. PMID 16892358 DOI: 10.1002/Cmdc.200500039  0.4
2006 Wersinger C, Rusnak M, Sidhu A. Modulation of the trafficking of the human serotonin transporter by human alpha-synuclein. The European Journal of Neuroscience. 24: 55-64. PMID 16882008 DOI: 10.1111/j.1460-9568.2006.04900.x  0.4
2004 Sidhu A, Wersinger C, Moussa CE, Vernier P. The role of alpha-synuclein in both neuroprotection and neurodegeneration. Annals of the New York Academy of Sciences. 1035: 250-70. PMID 15681812 DOI: 10.1196/Annals.1332.016  0.4
2004 Vernier P, Moret F, Callier S, Snapyan M, Wersinger C, Sidhu A. The degeneration of dopamine neurons in Parkinson's disease: insights from embryology and evolution of the mesostriatocortical system. Annals of the New York Academy of Sciences. 1035: 231-49. PMID 15681811 DOI: 10.1196/Annals.1332.015  0.4
2004 Moussa CE, Wersinger C, Rusnak M, Tomita Y, Sidhu A. Abnormal migration of human wild-type alpha-synuclein upon gel electrophoresis. Neuroscience Letters. 371: 239-43. PMID 15519765 DOI: 10.1016/j.neulet.2004.09.004  0.4
2004 Chen J, Rusnak M, Luedtke RR, Sidhu A. D1 dopamine receptor mediates dopamine-induced cytotoxicity via the ERK signal cascade. The Journal of Biological Chemistry. 279: 39317-30. PMID 15247297 DOI: 10.1074/jbc.M403891200  0.4
2004 Le Crom S, Sugamori KS, Sidhu A, Niznik HB, Vernier P. Delineation of the conserved functional properties of D1A, D1B and D1C dopamine receptor subtypes in vertebrates. Biology of the Cell / Under the Auspices of the European Cell Biology Organization. 96: 383-94. PMID 15207908 DOI: 10.1016/J.Biolcel.2004.03.002  0.4
2004 Sidhu A, Wersinger C, Vernier P. alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease. Febs Letters. 565: 1-5. PMID 15135042 DOI: 10.1016/J.Febslet.2004.03.063  0.4
2004 Sidhu A, Wersinger C, Vernier P. Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse? Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 18: 637-47. PMID 15054086 DOI: 10.1096/Fj.03-1112Rev  0.4
2004 Wersinger C, Banta M, Sidhu A. Comparative analyses of alpha-synuclein expression levels in rat brain tissues and transfected cells. Neuroscience Letters. 358: 95-8. PMID 15026157 DOI: 10.1016/j.neulet.2003.12.118  0.4
2004 Wersinger C, Vernier P, Sidhu A. Trypsin disrupts the trafficking of the human dopamine transporter by alpha-synuclein and its A30P mutant. Biochemistry. 43: 1242-53. PMID 14756560 DOI: 10.1021/Bi035308S  0.4
2003 Wersinger C, Prou D, Vernier P, Niznik HB, Sidhu A. Mutations in the lipid-binding domain of alpha-synuclein confer overlapping, yet distinct, functional properties in the regulation of dopamine transporter activity. Molecular and Cellular Neurosciences. 24: 91-105. PMID 14550771 DOI: 10.1016/S1044-7431(03)00124-6  0.4
2003 Wersinger C, Prou D, Vernier P, Sidhu A. Modulation of dopamine transporter function by alpha-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 17: 2151-3. PMID 12958153 DOI: 10.1096/Fj.03-0152Fje  0.4
2003 Shin Y, Kumar U, Patel Y, Patel SC, Sidhu A. Differential expression of D2-like dopamine receptors in the kidney of the spontaneously hypertensive rat. Journal of Hypertension. 21: 199-207. PMID 12544452 DOI: 10.1097/01.hjh.0000045534.21915.88  0.4
2001 Ong WY, Kumar U, Switzer RC, Sidhu A, Suresh G, Hu CY, Patel SC. Neurodegeneration in Niemann-Pick type C disease mice. Experimental Brain Research. 141: 218-31. PMID 11713633 DOI: 10.1007/s002210100870  0.4
2000 Sidhu A, Niznik HB. Coupling of dopamine receptor subtypes to multiple and diverse G proteins. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 18: 669-77. PMID 10978845 DOI: 10.1016/S0736-5748(00)00033-2  0.4
1998 Sidhu A, Banta M, Uh M, Shin Y. Photoaffinity labeling of D1 and D5 dopamine receptors. Neuroscience. 82: 1095-101. PMID 9466433 DOI: 10.1016/S0306-4522(97)00345-X  0.4
1991 Laruelle M, Sidhu A, Casanova MF, Weinberger DR, Kleinman JE. Characterization of [125I]SCH 23982 binding in human brain: comparison with [3H]SCH 23390. Neuroscience Letters. 131: 273-6. PMID 1837073 DOI: 10.1016/0304-3940(91)90631-3  0.4
Show low-probability matches.